Emyria Limited is on track to open its first Empax clinic in Victoria by Q2 2026, having secured key operational milestones including a trained clinical workforce and dual reimbursement pathways.
- 31 Victorian therapists contracted and trained
- 4 psychiatrists trained with 2 more scheduled
- Medication supply secured and agreements finalized with Avive Health
- Dual reimbursement via Medibank Private and Department of Veterans’ Affairs
- Clinic launch on track for Q2 2026
Emyria Advances Victorian Expansion
Emyria Limited (ASX:EMD), a pioneer in innovative mental health treatments, has announced that its first Empax clinic in Victoria is progressing well and remains on schedule to begin patient treatments in the second quarter of 2026. This development marks a significant milestone in the company’s national rollout strategy, aiming to broaden access to reimbursable, evidence-based therapies for conditions such as treatment-resistant depression and post-traumatic stress disorder.
Building a Robust Clinical Workforce
Central to the clinic’s readiness is the successful recruitment and training of 31 therapists and 4 psychiatrists, with two additional psychiatrists set to complete training shortly. This growing network of authorised prescribers and therapists substantially de-risks the clinic’s operational launch and supports scalable patient throughput, positioning the clinic for a smooth ramp-up phase post-launch.Operational and Partnership Milestones
Emyria has secured medication supply and finalised a full form agreement with Avive Health, the site partner, enabling minor fit-out works to commence at the Mornington Peninsula licensed hospital. The company is also negotiating pharmacy agreements and integrating clinical governance processes with Avive Health, further reducing execution risk and paving a clear path to revenue generation.Dual Reimbursement Pathways Enhance Revenue Visibility
Importantly, the clinic benefits from dual reimbursement channels: Medibank Private will fund eligible patients accessing Empax programs, while the Department of Veterans’ Affairs provides funding for eligible veterans. This dual funding model reduces reliance on self-funded patients and underpins early utilisation rates, enhancing revenue visibility for Emyria as it scales its Empax model nationally.Looking Ahead
With all regulatory, clinical, and operational workstreams progressing as planned, Emyria’s Victorian Empax clinic launch is poised to expand the company’s footprint and treatment capacity. Executive Chairman Greg Hutchinson emphasised the company’s confidence in the clinic’s potential to drive growth and improve access to reimbursable mental health treatments, highlighting the strategic importance of this milestone in Emyria’s broader vision.Bottom Line?
As Emyria prepares to open its Victorian Empax clinic, investors will watch closely how patient uptake and reimbursement pathways translate into sustainable revenue growth.
Questions in the middle?
- How quickly will patient volumes ramp up following the clinic’s launch?
- What impact will dual reimbursement pathways have on long-term clinic utilisation?
- How will Emyria manage potential regulatory or clinical risks associated with psychedelic-assisted therapies?